<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-D23VY79Y/488ff74a-3606-48be-8d1c-74bcf56ec027/PDF"><dcterms:extent>2054 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-D23VY79Y/0411ecd4-02a1-4b1b-9d95-eef58a15d9e0/TEXT"><dcterms:extent>9 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-D23VY79Y"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:SPR-WQVGMCSC" /><dcterms:issued>1995</dcterms:issued><dc:creator>Fadel, A...</dc:creator><dc:creator>Peruzzo, S...</dc:creator><dc:creator>Peserico, A...</dc:creator><dc:creator>Veller-Fornasa, C...</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:4</dc:format><dc:format xml:lang="sl">str. 27-30</dc:format><dc:identifier>ISSN:1318-4458</dc:identifier><dc:identifier>COBISSID_HOST:3684057</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-D23VY79Y</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovene Welding Society</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta dermatovenerologica Alpina, Pannonica et Adriatica</dcterms:isPartOf><dc:subject xml:lang="sl">Cyclosporine</dc:subject><dc:subject xml:lang="sl">Drug therapy</dc:subject><dc:subject xml:lang="sl">Iga</dc:subject><dc:subject xml:lang="sl">Paraproteinemias</dc:subject><dc:subject xml:lang="sl">Prednisone</dc:subject><dc:subject xml:lang="sl">Pyoderma gangrenosum</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Pyoderma gangrenosum associated with IgA paraproteinemia: treatment with cyclosporin A and prednisone|</dc:title><dc:description xml:lang="sl">A 58-year-old woman with a 20-year history of recalcitrant pyoderma gangrenosum asssociated with IgA paraproteinemia was treated with cyclosporin A 5 mg/kg/day combined with prednisone 30 mg/day without significant amelioration. After raising the dose of cyclosporin A to 10 mg/kg a rapid improvement was observed. Subsequently the cyclosporin A and prednisone doses were reduced progressively and a complete cure was achieved after 7 months of treatment. Three years later no relapse has occurred on a maintenance therapy consisting of 3 mg/kg/day of cyclosporin A and 6 mg/day of prednisone</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-D23VY79Y"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-D23VY79Y" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-D23VY79Y/488ff74a-3606-48be-8d1c-74bcf56ec027/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Združenje slovenskih dermatovenerologov</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-D23VY79Y/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-D23VY79Y" /></ore:Aggregation></rdf:RDF>